ReviewCancer immunology, immunotherapy : CII2018

Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.

Katerina Pilatova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.